RNS Number : 1684E Renalytix PLC 26 October 2022 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders
RNS Number : 9479D Renalytix PLC 25 October 2022 Renalytix plc ("Renalytix" or the "Company") KidneyIntelX Medicare Update NEW YORK and SALT LAKE CITY , October 25, 2022 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced that, building on recently established private payer and
RNS Number : 7880D Renalytix PLC 24 October 2022 Renalytix plc ("Renalytix" or the "Company") Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2022 on October 31 NEW YORK and SALT LAKE CITY , October 24, 2022 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today
RNS Number : 0165D Renalytix PLC 17 October 2022 KidneyIntelX Clinical Utility and Health Economics Validated in Multiple Data Releases at American Society of Nephrology Four presentations, including first clinical utility findings from multi-year real world evidence results from a major
RNS Number : 9534Z Renalytix PLC 20 September 2022 Renalytix plc ("Renalytix" or the "Company") Renalytix Announces Change to Board of Directors LONDON and SALT LAKE CITY , 20 September 2022 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that Ann Berman , non-executive director
RNS Number : 0215Z Renalytix PLC 12 September 2022 Renalytix plc ("Renalytix" or the "Company") Issue of shares NEW YORK and SALT LAKE CITY , 12 September, 2022 - Renalytix Plc (NASDAQ: RNLX) (LSE: RENX) announces that under the Company's Employee Share Purchase Plan (the "ESPP"),
RNS Number : 6200Y Renalytix PLC 08 September 2022 Renalytix to Present at H.C. Wainwright 24th Annual Global Investment Conference NEW YORK, NY and SALT LAKE CITY, UT ̶ September 8, 2022 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the company will participate in a
RNS Number : 3072W Renalytix PLC 17 August 2022 This contains inside information Renalytix plc ("Renalytix" or the "Company") Business update NEW YORK, NY and SALT LAKE CITY, UT August 17, 2022 (GLOBE NEWSWIRE) - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) provides the following business
RNS Number : 1019V Renalytix PLC 08 August 2022 Renalytix plc ("Renalytix" or the "Company") Data Results Published in American Journal of Managed Care demonstrate adoption and clinical utility of KidneyIntelX TM with Primary Care Physicians 98% of 401 Primary Care Physicians confirmed
RNS Number : 7475Q Renalytix PLC 30 June 2022 Renalytix plc ("Renalytix" or the "Company") Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2022 LONDON and SALT LAKE CITY , June 30, 2022 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in
